Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

68Ga-DOTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumours.

Sharma R, Wang WM, Yusuf S, Evans J, Ramaswami R, Wernig F, Frilling A, Mauri F, Al-Nahhas A, Aboagye EO, Barwick TD.

Radiother Oncol. 2019 Sep 18. pii: S0167-8140(19)33076-2. doi: 10.1016/j.radonc.2019.09.003. [Epub ahead of print]

PMID:
31542317
2.

Radioembolisation with 90Y microspheres for neuroendocrine liver metastases: an institutional case series, systematic review and meta-analysis.

Frilling A, Clift AK, Braat AJAT, Alsafi A, Wasan HS, Al-Nahhas A, Thomas R, Drymousis P, Habib N, Tait PN.

HPB (Oxford). 2019 Jul;21(7):773-783. doi: 10.1016/j.hpb.2018.12.014. Epub 2019 Feb 5. Review.

PMID:
30733049
3.

Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumours.

Alsadik S, Yusuf S, Al-Nahhas A.

Curr Radiopharm. 2019;12(2):126-134. doi: 10.2174/1874471012666190201164132.

PMID:
30714538
4.

Neoadjuvant peptide receptor radionuclide therapy and modified multivisceral transplantation for an advanced small intestinal neuroendocrine neoplasm: an updated case report.

Clift AK, Giele H, Reddy S, Macedo R, Al-Nahhas A, Wasan HS, Gondolesi GE, Vianna RM, Friend P, Vaidya A, Frilling A.

Innov Surg Sci. 2017 Aug 25;2(4):247-253. doi: 10.1515/iss-2017-0025. eCollection 2017 Dec.

5.

FDG Uptake by Prosthetic Arterial Grafts in Large Vessel Vasculitis Is Not Specific for Active Disease.

Youngstein T, Tombetti E, Mukherjee J, Barwick TD, Al-Nahhas A, Humphreys E, Nash J, Andrews J, Incerti E, Tombolini E, Salerno A, Sartorelli S, Ramirez GA, Papa M, Sabbadini MG, Gianolli L, De Cobelli F, Fallanca F, Baldissera E, Manfredi AA, Picchio M, Mason JC.

JACC Cardiovasc Imaging. 2017 Sep;10(9):1042-1052. doi: 10.1016/j.jcmg.2016.09.027. Epub 2017 Jan 18.

6.

Evaluation of 18F-fluorothymidine positron emission tomography ([18F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer.

Sharma R, Mapelli P, Hanna GB, Goldin R, Power D, Al-Nahhas A, Merchant S, Ramaswami R, Challapalli A, Barwick T, Aboagye EO.

EJNMMI Res. 2016 Dec;6(1):81. Epub 2016 Nov 16.

7.

Hypoxia and tissue destruction in pulmonary TB.

Belton M, Brilha S, Manavaki R, Mauri F, Nijran K, Hong YT, Patel NH, Dembek M, Tezera L, Green J, Moores R, Aigbirhio F, Al-Nahhas A, Fryer TD, Elkington PT, Friedland JS.

Thorax. 2016 Dec;71(12):1145-1153. doi: 10.1136/thoraxjnl-2015-207402. Epub 2016 May 31.

8.

Clinical Translation of a Click-Labeled 18F-Octreotate Radioligand for Imaging Neuroendocrine Tumors.

Dubash SR, Keat N, Mapelli P, Twyman F, Carroll L, Kozlowski K, Al-Nahhas A, Saleem A, Huiban M, Janisch R, Frilling A, Sharma R, Aboagye EO.

J Nucl Med. 2016 Aug;57(8):1207-13. doi: 10.2967/jnumed.115.169532. Epub 2016 May 12.

9.

Yttrium-90 radiation synovectomy revisited.

Merashli M, Al-Nahhas A, Jawad AS.

Nucl Med Commun. 2016 Jan;37(1):99-100. doi: 10.1097/MNM.0000000000000408. No abstract available.

PMID:
26587984
10.

Glucagon increases energy expenditure independently of brown adipose tissue activation in humans.

Salem V, Izzi-Engbeaya C, Coello C, Thomas DB, Chambers ES, Comninos AN, Buckley A, Win Z, Al-Nahhas A, Rabiner EA, Gunn RN, Budge H, Symonds ME, Bloom SR, Tan TM, Dhillo WS.

Diabetes Obes Metab. 2016 Jan;18(1):72-81. doi: 10.1111/dom.12585. Epub 2015 Nov 20.

11.

Role of Staging in Patients with Small Intestinal Neuroendocrine Tumours.

Clift AK, Faiz O, Al-Nahhas A, Bockisch A, Liedke MO, Schloericke E, Wasan H, Martin J, Ziprin P, Moorthy K, Frilling A.

J Gastrointest Surg. 2016 Jan;20(1):180-8; discussion 188. doi: 10.1007/s11605-015-2953-6. Epub 2015 Sep 22.

PMID:
26394880
12.

Transplantation and Debulking Procedures for Neuroendocrine Tumors.

Frilling A, Al-Nahhas A, Clift AK.

Front Horm Res. 2015;44:164-76. doi: 10.1159/000382145. Epub 2015 Aug 14. Review.

PMID:
26303711
13.

Incidence of Second Primary Malignancies in Patients with Neuroendocrine Tumours.

Clift AK, Drymousis P, Al-Nahhas A, Wasan H, Martin J, Holm S, Frilling A.

Neuroendocrinology. 2015;102(1-2):26-32. doi: 10.1159/000381716. Epub 2015 Mar 21. Review.

PMID:
25824138
14.

Modified liver-free multivisceral transplantation for a metastatic small bowel neuroendocrine tumor: a case report.

Frilling A, Giele H, Vrakas G, Reddy S, Macedo R, Al-Nahhas A, Wasan H, Clift AK, Gondolesi GE, Vianna RM, Friend P, Vaidya A.

Transplant Proc. 2015 Apr;47(3):858-62. doi: 10.1016/j.transproceed.2015.01.007. Epub 2015 Feb 15.

PMID:
25689880
15.

Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.

Tran K, Khan S, Taghizadehasl M, Palazzo F, Frilling A, Todd JF, Al-Nahhas A.

Hell J Nucl Med. 2015 Jan-Apr;18(1):19-24. doi: 10.1967/s002449910163. Epub 2015 Feb 13.

16.

Utility of left lateral supine position for myocardial perfusion single-photon emission computed tomography compared with other methods of correcting inferior wall attenuation.

Sayman HB, Kanmaz B, Uslu I, Al-Nahhas A, Cuocolo A, Carril JM, Cinaral F, El-Refaei S, Senocak M.

Nucl Med Commun. 2015 Mar;36(3):268-78. doi: 10.1097/MNM.0000000000000237.

PMID:
25356619
17.

The value of combined assessment of vertebral fractures with 99mTc MDP scintigraphy and MRI in selecting and planning percutaneous vertebroplasty.

ap Dafydd D, Salem S, Zerizer I, Yan Mok W, Gishen P, Patel MC, Patel NH, Al-Nahhas A, Dunn J, Win Z.

Nucl Med Commun. 2014 Jul;35(7):755-61. doi: 10.1097/MNM.0000000000000110.

PMID:
24694774
18.

Frequency and significance of physiological versus pathological uptake of 68Ga-DOTATATE in the pancreas: validation with morphological imaging.

Mapelli P, Tam HH, Sharma R, Aboagye EO, Al-Nahhas A.

Nucl Med Commun. 2014 Jun;35(6):613-9. doi: 10.1097/MNM.0000000000000106.

PMID:
24686250
19.

Biodistribution and radiation dosimetry of deuterium-substituted 18F-fluoromethyl-[1, 2-2H4]choline in healthy volunteers.

Challapalli A, Sharma R, Hallett WA, Kozlowski K, Carroll L, Brickute D, Twyman F, Al-Nahhas A, Aboagye EO.

J Nucl Med. 2014 Feb;55(2):256-63. doi: 10.2967/jnumed.113.129577.

20.

Exploring the potential of [11C]choline-PET/CT as a novel imaging biomarker for predicting early treatment response in prostate cancer.

Challapalli A, Barwick T, Tomasi G, O' Doherty M, Contractor K, Stewart S, Al-Nahhas A, Behan K, Coombes C, Aboagye EO, Mangar S.

Nucl Med Commun. 2014 Jan;35(1):20-9. doi: 10.1097/MNM.0000000000000014.

PMID:
24201549
21.

Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging.

Chondrogiannis S, Marzola MC, Al-Nahhas A, Venkatanarayana TD, Mazza A, Opocher G, Rubello D.

Nucl Med Commun. 2013 Dec;34(12):1141-9. doi: 10.1097/MNM.0000000000000008. Review.

22.

18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry.

Challapalli A, Kenny LM, Hallett WA, Kozlowski K, Tomasi G, Gudi M, Al-Nahhas A, Coombes RC, Aboagye EO.

J Nucl Med. 2013 Sep;54(9):1551-6. doi: 10.2967/jnumed.112.118760. Epub 2013 Aug 15.

23.

(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position.

Tartaglione G, D'Addessi A, De Waure C, Pagan M, Raccioppi M, Sacco E, Cadeddu C, Vittori M, Bassi PF, Ferretti A, Al-Nahhas A, Rubello D.

Clin Nucl Med. 2013 Jun;38(6):432-6. doi: 10.1097/RLU.0b013e31828da3f5.

PMID:
23603586
24.

Correlative imaging with (18)F-FDG PET/CT and MRI in paraneoplastic limbic encephalitis.

Maffione AM, Chondrogiannis S, Ferretti A, Al-Nahhas A, Rubello D.

Clin Nucl Med. 2013 Jun;38(6):463-4. doi: 10.1097/RLU.0b013e318286bda5.

PMID:
23531769
25.

68Ga DOTATATE PET/CT uptake in spinal lesions and MRI correlation on a patient with neuroendocrine tumor: potential pitfalls.

Klinaki I, Al-Nahhas A, Soneji N, Win Z.

Clin Nucl Med. 2013 Dec;38(12):e449-53. doi: 10.1097/RLU.0b013e31827a2325.

PMID:
23531732
26.

Role of 18F-choline PET/CT in biochemically relapsed prostate cancer after radical prostatectomy: correlation with trigger PSA, PSA velocity, PSA doubling time, and metastatic distribution.

Marzola MC, Chondrogiannis S, Ferretti A, Grassetto G, Rampin L, Massaro A, Castellucci P, Picchio M, Al-Nahhas A, Colletti PM, Marcolongo A, Rubello D.

Clin Nucl Med. 2013 Jan;38(1):e26-32. doi: 10.1097/RLU.0b013e318266cc38.

PMID:
23242060
27.

Preoperative diagnosis of orbital cavernous hemangioma: a 99mTc-RBC SPECT study.

Burroni L, Borsari G, Pichierri P, Polito E, Toscano O, Grassetto G, Al-Nahhas A, Rubello D, Vattimo AG.

Clin Nucl Med. 2012 Nov;37(11):1041-6. doi: 10.1097/RLU.0b013e318252d2ed.

PMID:
23047756
28.

Nuclear medicine imaging of neuroendocrine tumours.

Al-Nahhas A.

Clin Med (Lond). 2012 Aug;12(4):377-80. No abstract available.

29.

EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma.

Taïeb D, Timmers HJ, Hindié E, Guillet BA, Neumann HP, Walz MK, Opocher G, de Herder WW, Boedeker CC, de Krijger RR, Chiti A, Al-Nahhas A, Pacak K, Rubello D; European Association of Nuclear Medicine.

Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1977-95. doi: 10.1007/s00259-012-2215-8. Epub 2012 Aug 28.

30.

Indeterminate pulmonary nodules on CT images in breast cancer patient: the additional value of 18F-FDG PET/CT.

Evangelista L, Panunzio A, Cervino AR, Vinante L, Al-Nahhas A, Rubello D, Muzzio PC, Polverosi R.

J Med Imaging Radiat Oncol. 2012 Aug;56(4):417-24. doi: 10.1111/j.1754-9485.2012.02408.x. Epub 2012 Jul 16.

PMID:
22883649
31.

The role of early ¹⁸F-FDG PET/CT in prediction of progression-free survival after ⁹⁰Y radioembolization: comparison with RECIST and tumour density criteria.

Zerizer I, Al-Nahhas A, Towey D, Tait P, Ariff B, Wasan H, Hatice G, Habib N, Barwick T.

Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1391-9. doi: 10.1007/s00259-012-2149-1. Epub 2012 May 30.

PMID:
22644713
32.

Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapy.

Contractor K, Challapalli A, Tomasi G, Rosso L, Wasan H, Stebbing J, Kenny L, Mangar S, Riddle P, Palmieri C, Al-Nahhas A, Sharma R, Turkheimer F, Coombes RC, Aboagye E.

Phys Med Biol. 2012 Jun 7;57(11):3419-33. doi: 10.1088/0031-9155/57/11/3419. Epub 2012 May 10.

PMID:
22572708
33.

Colorectal cancer: translation of biological pathways into molecular imaging.

Evangelista L, Marzola MC, Chondrogiannis S, Al-Nahhas A, Rubello D.

Nucl Med Commun. 2012 Jul;33(7):780-2. doi: 10.1097/MNM.0b013e32835405ab. No abstract available.

PMID:
22546875
34.

A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma.

Maurice JB, Troke R, Win Z, Ramachandran R, Al-Nahhas A, Naji M, Dhillo W, Meeran K, Goldstone AP, Martin NM, Todd JF, Palazzo F, Tan T.

Eur J Nucl Med Mol Imaging. 2012 Aug;39(8):1266-70. doi: 10.1007/s00259-012-2119-7. Epub 2012 Apr 20.

PMID:
22526961
35.

Tumor marker-guided PET in breast cancer patients-a recipe for a perfect wedding: a systematic literature review and meta-analysis.

Evangelista L, Cervino AR, Ghiotto C, Al-Nahhas A, Rubello D, Muzzio PC.

Clin Nucl Med. 2012 May;37(5):467-74. doi: 10.1097/RLU.0b013e31824850b0. Review.

PMID:
22475896
36.

Radiolabelled peptides in diagnosis and therapy: an introduction.

AL-Nahhas A, Fanti S.

Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S1-3. doi: 10.1007/s00259-012-2064-5. No abstract available.

PMID:
22388632
37.

⁶⁸Ga-labelled peptides in the management of neuroectodermal tumours.

Naji M, AL-Nahhas A.

Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S61-7. doi: 10.1007/s00259-011-1990-y. Review.

PMID:
22388623
38.

Modern nuclear imaging for paragangliomas: beyond SPECT.

Taïeb D, Neumann H, Rubello D, Al-Nahhas A, Guillet B, Hindié E.

J Nucl Med. 2012 Feb;53(2):264-74. doi: 10.2967/jnumed.111.098152. Review.

39.

Diagnostic and prognostic value of gated myocardial perfusion single-photon emission computed tomography in low-risk patients with left bundle-branch block.

Evangelista L, Nai Fovino L, Saladini F, Saladini G, Razzolini R, Mormino GP, Al-Nahhas A, Rubello D.

Nucl Med Commun. 2012 May;33(5):491-7. doi: 10.1097/MNM.0b013e328350855a.

PMID:
22262243
40.

Highlights of the EANM Congress 2011: Birmingham, UK.

de Geus-Oei LF, Zerizer I, Uebleis C, Al-Nahhas A.

Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):354-68. doi: 10.1007/s00259-011-2043-2.

PMID:
22237847
41.

FDG PET/CT in ovarian cancer: what about treatment response and prognosis?

Grassetto G, Groheux D, Marzola MC, Hindié E, Al-Nahhas A, Rubello D.

Clin Nucl Med. 2012 Jan;37(1):54-6. doi: 10.1097/RLU.0b013e3182336126. No abstract available.

PMID:
22157029
42.

In high risk hypertensive subjects with incidental and unilateral renal artery stenosis percutaneous revascularization with stent improves blood pressure control but not glomerular filtration rate.

Mazza A, Rigatelli G, Piva M, Rampin L, Cardaioli P, Giordan M, Roncon L, Zattoni L, Zuin M, Al-Nahhas A, Rubello D, Ramazzina E, Ravenni R, Casiglia E.

Minerva Cardioangiol. 2011 Dec;59(6):533-42.

PMID:
22134468
43.

Labelling of granulocytes by phagocytic engulfment with 64Cu-labelled chitosan-coated magnetic nanoparticles.

Pala A, Liberatore M, D'Elia P, Nepi F, Megna V, Mastantuono M, Al-Nahhas A, Rubello D, Barteri M.

Mol Imaging Biol. 2012 Oct;14(5):593-8. doi: 10.1007/s11307-011-0526-y.

PMID:
22083343
44.

18F-DOPA PET/CT biodistribution consideration in 107 consecutive patients with neuroendocrine tumours.

Chondrogiannis S, Grassetto G, Marzola MC, Rampin L, Massaro A, Bellan E, Ferretti A, Mazza A, Al-Nahhas A, Rubello D.

Nucl Med Commun. 2012 Feb;33(2):179-84. doi: 10.1097/MNM.0b013e32834e0974.

PMID:
22083098
45.

Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.

Contractor K, Challapalli A, Barwick T, Winkler M, Hellawell G, Hazell S, Tomasi G, Al-Nahhas A, Mapelli P, Kenny LM, Tadrous P, Coombes RC, Aboagye EO, Mangar S.

Clin Cancer Res. 2011 Dec 15;17(24):7673-83. doi: 10.1158/1078-0432.CCR-11-2048. Epub 2011 Oct 28.

46.

[18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxel.

Contractor KB, Kenny LM, Stebbing J, Rosso L, Ahmad R, Jacob J, Challapalli A, Turkheimer F, Al-Nahhas A, Sharma R, Coombes RC, Aboagye EO.

Clin Cancer Res. 2011 Dec 15;17(24):7664-72. doi: 10.1158/1078-0432.CCR-11-0783. Epub 2011 Oct 25.

47.

Renal scintigraphy predicts global cardiovascular risk in hypertensive subjects with normal serum creatinine levels.

Mazza A, Rampin L, Montemurro D, Schiavon L, Zuin M, Grassetto G, Chondrogiannis S, Al-Nahhas A, Ramazzina E, Rubello D.

Blood Press. 2011 Dec;20(6):387-93. doi: 10.3109/08037051.2011.622860. Epub 2011 Oct 24.

PMID:
22017389
48.

Noninvasive and invasive staging of ovarian cancer: review of the literature.

Fuccio C, Castellucci P, Marzola MC, Al-Nahhas A, Fanti S, Rubello D.

Clin Nucl Med. 2011 Oct;36(10):889-93. doi: 10.1097/RLU.0b013e318219b523. Review.

PMID:
21892039
49.

F-18 FDG PET/CT in rectal carcinoma: where are we now?

Grassetto G, Marzola MC, Minicozzi A, Al-Nahhas A, Rubello D.

Clin Nucl Med. 2011 Oct;36(10):884-8. doi: 10.1097/RLU.0b013e318219b507. Review.

PMID:
21892038
50.

Detection of unsuspected bone metastases by ⁶⁸Ga-DOTA: nuclear medicine at the forefront again.

Al-Nahhas A.

Nucl Med Commun. 2011 Oct;32(10):877-9. doi: 10.1097/MNM.0b013e32834ad802. No abstract available.

PMID:
21876397

Supplemental Content

Loading ...
Support Center